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ABSTRACT 
The  study  of  biological  indicator  organism  is  more  important  than  analyzing  water  or  sediments  for  monitoring  heavy  metal  pollution  in  the  aquatic 
environment .Non-essential elements enter the animals and accumulate to the different organs so that chelating agents are most versatile and effective antidotes 
to eliminate the metals toxicities. The aim of our present study is to find out bioaccumulations of aluminum and the effects of chelating agents DFO and DFP 
in Muscle, gill, kidney, brain and liver tissues of Cirrhinus mrigala by using Inductively Coupled Atomic Emission Spectrometer (ICP-AES). This study finds 
out the accumulation  of aluminum is Gill>Kidney. The present result  suggests  that  DFO and  DFP reduce the aluminum concentration in the tissues of 
Cirrhinus mrigala fingerlings and both are efficient chelators. Aluminum toxicity is a wide spread problem in all forms of life, including humans, animals, 
fishes, plants, and cause wide spread degradation of the environment and health.    
Key words: Bioaccumulation, aluminum, chelating agents, ICP-AES  
 
INTRODUCTION 
The estimation of aluminum concentration in the samples of 
fish has been made using an ICP-AES (ISA JOBIN YVON 
24 MODAL) and the analytical standard has prepared from 
the  aluminum  stock  solution.  Metal  contamination  from 
laboratory was avoided and triplicates of each sample were 
analyzed. The metal concentration in different tissue samples 
were calculated as follows
1, 2. 
Metal  concentration  (µg/g)  =  [ICP-AES  reading 
(µg/mL)/sample mass (g)] x samples volume (mL).  
 Bio  concentration  of  chemicals  by  aquatic  biota  is  an 
important factor in the assessment of the potential hazard of 
chemicals to the environment. The bio concentration factor or 
Biological Magnification Factor (BMF) is calculated as BMF 
=  K1/K2  =Chemical  concentration  in  each  part  of  the  fish 
(µg/g body weight)/ Chemical concentration in water (µg/L).  
Calculation  of  excretion  rate  constant  chemicals  from  the 
whole fish body/organ is 
C = C0 e
-k
2
t 
Where,  C =  Chemical  concentration in  whole  body/  organ 
(µg/g wet weight) at time t. 
 C0= Initial chemical concentration in whole fish body/ organ 
(µg/g wet weight). 
K2= Excretion rate constant (h
-1) and t= time (h
-1). 
Aluminum, which is the most abundant metal and comprises 
about 8% of the Earth's crust, is found in combination with 
oxygen, silicon, fluorine and other elements in the soil, rocks, 
clays  and  gems
3.  It  has  no  known  biological  function
4. 
Presently, aluminum utensils are widely used throughout the 
world, especially in developing countries
5. The use of such 
tools  may  increase  an  individual’s  aluminum  exposure, 
particularly when these are used with salty, acidic or alkaline 
foods
6. Additionally, aluminum and its salts are commonly 
used in daily life as it is believed that it is a non-toxic and is 
quickly excreted in the urine. However, this element can have 
negative  impact  human  and  animal  health
7.  Aluminum  is 
potentially  toxic  to  humans.  The  Agency  for  Toxic 
Substances  and  Disease  Registry  (ATSDR)
8,  reported  that 
aluminum  is  distributed  mainly  in  the  bone,  liver,  testis, 
kidneys and brain. In patients on dialysis
9 or on long-term 
total parenteral nutrition
10 this metal accumulates in different 
organs.  The  toxicological  effects  of  aluminum  in  humans 
include  encephalopathy
11bone  disease,  anemia  and  skeletal 
system  disease
12.  Furthermore,  aluminum  is  possibly  a 
contributing  factor  in  the  development  of  Alzheimer’s 
disease
13.  However,  this  remains  contradictory
14,  15.  The 
chelating  agents  possess  the  common  ability  to  form 
complexes with heavy metals and thereby prevent or reverse 
the binding of metallic captions to body legends. Chelating 
therapy is recommended for heavy metal poisoning. Heavy 
metals  exert  their  toxic  effects  by  combining  with  one  or 
more  reactive  groups  (legends)  essential  for  normal 
physiological  functions.  Deferroxamine  (DFO)  and 
Deferiprone (DFP) Chelating agents are designed specifically 
to  compete  with  these  groups  for  the  metals  and  thereby 
prevent or reverse toxic effects and enhance the excretion of 
metals.  DFO  is  the  principal  product  of  the  various  side 
amines  obtained  from  streptomyces  Pilosus
16.  Inductively 
Couple Plasma Atomic Emission spectroscopy (ICP-AES) is 
an  important  technique  to  study  the  trace  elements  at 
molecular level in various biological samples. It is a valuable 
technique due to its high sensitivity for detecting the major 
trace elements
17. 
MATERIAL AND METHODS  
Chemicals  
Aluminum sulphate (Al2 (SO4)3), purchased from S.D. Fine, 
chemicals limited, Mumbai, Deferroxamine (DFO) purchased 
from  Novartis  chemicals limited,  Mumbai  and  Deferiprone 
(DFP) purchased from Sigma,   chemicals limited ,Mumbai, 
India. 
Experimental Design 
Test  specimens  were  divided  in  to  eleven  groups  each 
consisted  of  20  fishes  and  stokes  in  20 liters  glass  trough 
equipped  with  continuous  air  supply.  The  test  water  was 
changed  daily  at  8  a.m.  morning  by  slowly  siphoning  of S. Sivakumar et al. IRJP 2012, 3 (7) 
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water from each container along with the waste fed and fecal 
material in Annamalai University, Tamilnadu-608002.  
Group-I: Fingerlings treated with metal free water.  
Group-II: Fingerlings intoxicated with 17.3 part per million 
(ppm) of Al2 (SO4)3 for 14 days.  
Group-III: (i) Fingerlings intoxicated with 17.3 ppm of Al2 
(SO4)3  for  14  days  (acute)  and  again  treated  with  DFO 
(5mg/kg b.wt.) for another 7 days.  
 (ii) Fingerlings intoxicated with 17.3 ppm of Al2 (SO4)3 for 
14 days (acute) and again treated with DFP (5mg/kg b.wt.) 
for another 7 days. 
Group-IV: (i) Fingerlings intoxicated with 5.2 ppm of Al2 
(SO4)3 for 15 days (chronic) 
Group-V:  Fingerlings  intoxicated  with  5.2  ppm  of  Al2 
(SO4)3  for  15  days  and  again  treated  with  DFO  (5mg/kg 
b.wt.) for another 15 days. 
(ii)  Fingerlings intoxicated with 5.2 ppm of Al2 (SO4)3 for 
15  days  and  again  treated  with  DFP  (5mg/kg  b.wt.)  for 
another 15 days.   
Group-VI:  Fingerlings  intoxicated  with  5.2  ppm  of  Al2 
(SO4)3 for 30 days (chronic). 
Group-VII:  Fingerlings  intoxicated  with  5.2  ppm  of  Al2 
(SO4)3  for  30  days  and  again  treated  with  DFO  (5mg/kg 
b.wt.)  for another 15 days. 
(ii) Fingerlings intoxicated with 5.2 ppm of Al2 (SO4)3 for 30 
days and again treated with DFP (5mg/kg b.wt.)  for another 
15 days. 
Group-VIII:  Fingerlings  intoxicated  with  5.2  ppm  of  Al2 
(SO4)3 for 60 days (chronic).  
Group-IX: (i) Fingerlings intoxicated with 5.2 ppm of Al2 
(SO4)3  for  60  days  and  again  treated  with  DFO  (5mg/kg 
b.wt.) for another 15 days. 
(ii) Fingerlings intoxicated with 5.2 ppm of Al2 (SO4)3 for 60 
days and again treated with DFP (5mg/kg b.wt.) for another 
15 days. 
Group-X: Fingerlings intoxicated with 5.2 ppm of Al2 
(SO4)3 for 90 days (chronic).  
Group-XI: (i) Fingerlings intoxicated with 5.2 ppm of Al2 
(SO4)3  for  90  days  and  again  treated  with  DFO  (5mg/kg 
b.wt.) for another 15 days. 
(ii) Fingerlings intoxicated with 5.2 ppm of Al2 (SO4)3 for 90 
days and again treated with DFP (5mg/kg b.wt.) for another 
15 days. 
Lethality Studies  
Experiments were conducted in the laboratory for 90 days in 
20  liters  glass  trough.  Unchlorinated  water  (pH  is  8.2, 
alkanity is 408 mg/L, temperature 27±2 
oc) was used as the 
test medium. Cirrhinus mrigala fingerlings of 4±1 cm and 
body weight 8±1 gm were used as testing organism. The fish 
specimens collected from the local pond were acclimatized in 
the  laboratory  condition  for  90  days
18.  Median  lethal 
concentration  (LC50)  for  120 hours  was  determined  by  the 
method  of  Litchfield  and  Welcoxon  (1949).The  sub-lethal 
concentration  of  aluminum  sulphate  was  prepared  on  the 
basis of ten times dilution of the LC50 value. Except control 
group  all  others  groups  were  again  treated  with  chelating 
agent DFO and DFP for another 15 days subsequently. All 
the control fingerlings were fed daily with oil less groundnut 
cake. End of the experimental period, subjected to estimate 
the aluminum in Brain, Liver tissues of Cirrhinus mrigala by 
using ICP-AES. 
 
 
Sample Preparation 
Dissecting  the  cirrhinus  mrigala  and  taken  out  the  gill, 
kidney. Then the samples were dried at 80 
0c for 24 hours. 
Then the samples were filled with 2N HNO3 overnight and 
rinsed several times with double distilled water. The samples 
were digested by weighing one gram of the sample into a 100 
mL  Borasil  flask  and  then  adding  15  ml  of  concentrated 
HNO3 (55%) and 5ml of concentrated Perchloric acid (70%). 
Digestion was performed on a hot plate at 80 to 90 
0c for 
approximately  120  minutes  or  until  the  solutions  become 
dried. After the digestion
19 was completed, each sample was 
allowed to cool before being filter through a whatman No. 42 
filter paper using vacuum pump. After filtration, the filtering 
system  was  rinsed  with  distilled  water to  remove  all  trace 
elements,  and  each  sample  was  made  up  to  25  mL  with 
distilled water and stored in acid-washed polyethylene flasks 
until the metal concentration analysis.     
STATISTICAL ANALYSIS   
Statistical  analysis  was  performed  using  SPSS  software 
program, version 11.5. The results were expressed as mean 
±  standard deviations. The data were analyzed by analysis 
of variance (ANOVA). A Probability level (p-value) of less 
than 0.05 was considered statistically significant.   
RESULTS AND DISCUSSION 
GILL 
It  was  observed  in  the  present  study  that  the  gill  tissue 
accumulate the amount of aluminum both in acute is 111.01 
µg/g  and  chronic  exposure  are  51.66  µg/g,  78.41  µg/g, 
101.21  µg/g  and  219.48  µg/g  at  15,30,60  and  90  days 
respectively  as  shown  in  Table-1.  Treatment  with  the 
chelating agents (DFO and DFP) reduced the concentration 
of aluminum significantly 58% and 56% for acute and 80%-
86%  for  chronic  and  74%-81%  for  chronic  exposure  as 
shown  in  Fig-1.  The  accumulation  and  discovery  of 
aluminum in acute and chronic exposures have been shown in 
Fig-2,  the  uptake  rate  decreases  slowly  upto  30  days  and 
remains constants upto 60 days and sudden decrease upto 90 
days as shown in Fig-2. The excretion rate decreases rapidly 
upto 90
 days. The excretion rate decreases rapidly upto 30 
days and afterwards it is slowly decreased upto 60 days and 
remains constant upto 90
 day as shown in Fig-3. Also the 
BMF  slowly  increased  upto  60  days  and  sudden  increases 
upto 90 days as shown in fig-4. It could be seen from Fig-2 
had  the  biggest  bioconcentration  factor  occurred  at  the 
chronic  exposure  level  (5.2  ppm  for  90  days).  At  this 
exposure  level,  the  gill  accumulated  approximately  42X 
amount of aluminum present in the ambient medium. At the 
highest exposure level (17.33 ppm), the gill accumulated the 
least amount of aluminum (~ 6X). Uptake rate is low and 
elimination rate is high in the acute exposure (k1= 0.0536 h
-1 
and  K2=  0.0.0048  h
-1)  compare  to  chronic  exposure  (k1= 
0.06815 h
-1 and K2= 0.0016 h
-1). The elimination rate is very 
low in chronic exposure and it remains almost constant after 
30 days, which leads to the maximum BMF (42X) as shown 
in Fig-4. 
The  gills  are  predominant  barrier-mechanism  preventing 
absorption  of  bioavailability  metals  from  external  medium. 
Hence, metal distribution in the gills can help understand the 
mechanism of uptake in fish. The significant concentration in 
the gills may be due to the mucous layer covering the organ 
and  its  close  contact  with  the  surrounding  medium.  The 
increase  in  salinity  influenced  Al  speciation,  where  toxic S. Sivakumar et al. IRJP 2012, 3 (7) 
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forms of aluminum speciation, where toxic forms of Al were 
remobilized  from  the  non-toxic  colloidal  forms  present  in 
fresh  water.  Plasma  chloride  was  reduced  to  concentration 
between 120 to 130 mm in dying fish, suggesting that the fish 
died  from  hypoxia  rather  than  ionoregularoty  disturbance. 
Fish responses were related to the accumulation of Al on the 
gills. The observed responses can explain some of the fish 
gills that have been described from fish forms
20. Al acts as 
exogenously on the gill there by impairing respiration, and/or 
endogenously  damages  the  gills
21.  Aluminum  toxicity 
includes  both  the  apical  and  intracellular  accumulation  of 
aluminum at the gill epithelium
22.  
KIDNEY 
From  Table-2    the  kidney  tissues  accumulated  a  higher 
amount of aluminum 106.52 µg/g for acute and for chronic 
35.50 µg/g, 44.51 µg/g, 47.61 µg/g, 112.50 µg/g at15, 30, 60 
and 90 days respectively. Treatment with the chelating agents 
DFO and DFP reduced the concentration of aluminum in the 
kidney to 60.28 µg/g for acute and for chronic 16.45 µg/g, 
19.50  µg/g,  26.75  µg/g  and  30.57  µg/g,  30.57  µg/g,  and 
49.75 µg/g, 13.73 µg/g, 17.50 µg/g, 20.52 µg/g, and 29.67 
µg/g  for  15,30,60,90  days  respectively  as  shown  in  Fig-5. 
The accumulation and elimination of aluminum in acute and 
chronic  exposure  and  the  variation  of  the  uptake  and 
excretion rate constants during chronic exposure are shown in 
Fig-5,  Fig-6  and  Fig-7  respectively.  The  uptake  rate 
decreased  gradually  upto  60  days  and  increased  suddenly 
afterwards upto 90 days as shown in Fig-6, on the other hand 
the excretion rate is gradually decreased from 15 days to 90 
days as shown in Fig-7. BMF values are increasing slowly 
for 15 to 60 days and afterwards increasing rapidly as shown 
in Fig-8. It is inverse manner as that of excretion rate. From 
the comparison of uptake rate and BMF of kidney tissues it 
could be seen that the greatest biological magnification factor 
occurred at the chronic exposure 90 days. At this exposure 
level, the kidney accumulated approximately 22X amount of 
aluminum present in the ambient medium. As the exposure 
concentration increases the BMF is reduced. At the highest 
exposure level the kidney accumulated the least amount of 
aluminum  approximately  6X.  Also  the  uptake  rate  is  low 
elimination rate is high in the acute exposure k1= 0.0563 h
-1 
and  K2=  0.0092 h
-1  compared  to  the  chronic  exposure  k1= 
0.0563 h
-1 and k2= 0.0015 h
-1as shown in Table-2. The very 
low  elimination rate during  the  chronic  exposures  leads to 
maximum  BMF  was  22X.The  treatment  of  the  chelating 
agents DFO and DFP reduced the concentration of aluminum 
significantly 43% and 53% (acute), 61% to 73% and 54% to 
74%  (chronic)  as  shown  in  Fig-5.  The  excretory  organs 
usually accumulate large quantities of metals especially in the 
fish  and  animals.  During  the  excretion  process  the  excess 
amount  of  aluminum  ions  are  rapidly  eliminated  from  the 
body through the kidney mainly detoxification mechanism. 
Hence kidney is clearly a major target organ for both acute 
and  chronic  aluminum  exposures
23.  Aluminum  overload  in 
renal patients causes a number of diseases such as Dementia, 
Alzheimer’s disease, and memory loss
24. 
CONCLUSION 
It has been found in the present study that the accumulation 
pattern  follows  the  order:  Gill>Kidney  by  using  ICP-AES. 
Chelating agents are most versatile and effective antidotes for 
metals intoxication and stable complexes, which can handily 
get accumulated in organisms, thereby reducing the toxicity 
of the metals to organisms. The present study suggests that in 
from ICP-AES is best instrument to find out the DFO and 
DFP  reduced  the  aluminum  concentration in  the  Cirrhinus 
mrigala fingerlings was found and the BMF is low for acute 
duration exposure.   
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Table-1: Accumulation, recovery, uptake, excretion rate and BMF of aluminum in the gills tissue of Cirrhinus mrigala at acute and chronic exposures. 
Gill  Periods of exposure 
Control  14 days  15 days  30 days  60 days  90 days 
Al intoxicated  6.68  111.O1  51.66  78.41  101.21  219.48 
Al+ DFO  6.68  49.31  12.81  26.75  30.72  59.62 
Al+ DFP  6.68  46.18  10.41  17.35  19.78  51.89 
K1    0.0536  0.0565  0.0387  0.0367  0.0681 
K2    0.0048  0.0057  0.0026  0.0019  0.0016 
BMF    6X  10X  15X  20X  42X 
Values are statistically significant between the control and treated is p<0.05. 
 
Table-2: Accumulation, recovery, uptake, excretion rate and BMF of aluminum in the Kidney tissues of Cirrhinus mrigala at acute and chronic exposures. 
Kidney  Periods of exposure 
Control  14 days  15 days  30 days  60 days  90 days 
Al intoxicated  4.852  106.52  35.50  44.51  47.61  112.50 
Al+ DFO  4.852  60.28  16.45  19.50  26.75  30.57 
Al+ DFP  4.852  49.75  13.73  17.50  20.52  29.67 
K1    0.0563  0.0378  0.0198  0.0145  0.0315 
K2    0.0092  0.0055  0.0023  0.0016  0.0015 
BMF    6X  7X  8X  9X  22X 
Values are statistically significant between the control and treated is p<0.05. 
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Fig. 1:  Bioaccumualtion and elimination of Aluminium in Gill tissues during acute and chronic exposure 
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Fig. 2:  Uptake rate (k1) of Gill tissues during acute and chronic exposures 
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Fig. 3:  Excretion rate (k2) of Gill tissues during acute and chronic exposures 
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Fig. 4:  BMF of Gill tissues during acute and chronic exposures 
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Fig. 5:  Bioaccumualtion and elimination of Aluminium in Kidney tissues during acute and chronic exposure 
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Fig. 6:  Uptake rate (k1) of Kidney tissues during acute and chronic exposures 
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Fig. 7:  Excretion rate (k2) of Kidney tissues during acute and chronic exposures 
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Fig. 8:  BMF of Kidney tissues during acute and chronic exposures 
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